Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Carcinoma of the Lungs”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT00101348
What this trial is testing

Erlotinib and Cetuximab With or Without Bevacizumab in Treating Patients With Metastatic or Unresectable Kidney, Colorectal, Head and Neck, Pancreatic, or Non-Small Cell Lung Cancer

Who this might be right for
Metastatic Squamous Neck Cancer With Occult Primary Squamous Cell CarcinomaRecurrent Adenoid Cystic Carcinoma of the Oral CavityRecurrent Basal Cell Carcinoma of the Lip+64 more
National Cancer Institute (NCI) 66
Not applicableLooking for participantsNCT06780826
What this trial is testing

A Study on the Efficacy of Atezolizumab Combined with Chemotherapy

Who this might be right for
Lung Cancer, Small Cell
Shanghai Pulmonary Hospital, Shanghai, China 1,430
Not applicableStudy completedNCT01517971
What this trial is testing

Studying Tumor Tissue Samples From Patients With Early-Stage Non-Small Cell Lung Cancer

Who this might be right for
Lung Cancer
Alliance for Clinical Trials in Oncology 1,060
Not applicableLooking for participantsNCT06732193
What this trial is testing

Fissios© and Postoperative Complications (FPoC Trial)

Who this might be right for
Surgical Procedure, UnspecifiedNon Small Cell Lung CancerSurgery Scheduled+3 more
Carlos Alfredo Fraile Olivero, MD, PhD. 560
Early research (Phase 1)Study completedNCT04452214
What this trial is testing

The Safety and Tolerance of CAN04 and Pembrolizumab in Combination With and Without Carboplatin and Pemetrexed in Subjects With Solid Tumors

Who this might be right for
Carcinoma, Non-Small-Cell LungUrothelial CarcinomaMalignant Melanoma+1 more
Cantargia AB 19
Testing effectiveness (Phase 2)Ended earlyNCT03773133
What this trial is testing

Evaluate the Safety, Tolerability, Biodistribution and Anti Tumour Activity of 177LU-OPS201 With Companion Imaging 68Ga-OPS202 PET/CT in Previously Treated Subjects With Locally Advanced or Metastatic Cancers Expressing Somatostatin Receptor 2 (SSTR2)

Who this might be right for
Small Cell Lung Cancer and Breast Cancer
Ipsen 9
Not applicableStudy completedNCT05154344
What this trial is testing

RW Effectiveness of Capmatinib in Advanced MET-dysregulated NSCLC Included in the French Compassionate Use Program (ATU)

Who this might be right for
MET AlterationsNon Small Cell Lung CancerMETex14 Mutations
Intergroupe Francophone de Cancerologie Thoracique 182
Testing effectiveness (Phase 2)Study completedNCT04311034
What this trial is testing

RC48-ADC in Subjects With Advanced Non-small Cell Lung Cancer

Who this might be right for
Non Small Cell Lung Cancer
RemeGen Co., Ltd. 37
Early research (Phase 1)UnknownNCT04487093
What this trial is testing

Clinical Study of Neoantigen Vaccine Combined With Targeted Drugs in the Treatment of Non-small Cell Lung Cancer

Who this might be right for
Non Small Cell Lung Cancer
First Hospital of Shijiazhuang City 20
Testing effectiveness (Phase 2)UnknownNCT00006116
What this trial is testing

Combination Chemotherapy in Treating Patients With Stage IIIB or Stage IV Non-Small Cell Lung Cancer

Who this might be right for
Lung Cancer
GERCOR - Multidisciplinary Oncology Cooperative Group
Large-scale testing (Phase 3)Not Yet RecruitingNCT07728955
What this trial is testing

A Single-arm, Exploratory Clinical Study Evaluating the Efficacy and Safety of Bevacizumab in Combination With Anlotinib and Etoposide as First-line Therapy for Elderly Patients With Small-cell Lung Cancer or Those Who Are Intolerant to Intensive Chemotherapy

Who this might be right for
Small Cell Lung Cancer ( SCLC )
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University 64
Testing effectiveness (Phase 2)Active Not RecruitingNCT05488314
What this trial is testing

Amivantamab and Capmatinib Combination Therapy in Unresectable Metastatic Non-small Cell Lung Cancer

Who this might be right for
Carcinoma, Non-Small-Cell Lung
Janssen Research & Development, LLC 57
Not applicableStudy completedNCT03170284
What this trial is testing

Observational Study to Evalute the Efficacy and Safety of Avastin (Bevacizumab) in Addition to Platinum-Based Chemotherapy for First-Line Treatment of Participants With Non-Small Cell Lung Cancer

Who this might be right for
Carcinoma, Non-Small-Cell Lung
Hoffmann-La Roche 150
Large-scale testing (Phase 3)Looking for participantsNCT05317858
What this trial is testing

Blood-brain Barrier (BBB) Opening Using Exablate Focused Ultrasound With Standard of Care Treatment of NSCLC Brain Mets

Who this might be right for
Brain TumorNon Small Cell Lung Cancer
InSightec 30
Large-scale testing (Phase 3)Looking for participantsNCT06357533
What this trial is testing

Phase III, Open-label, Study of First-line Dato-DXd in Combination With Rilvegostomig for Advanced Non-squamous NSCLC With High PD-L1 Expression (TC ≥ 50%) and Without Actionable Genomic Alterations

Who this might be right for
Non-Small Cell Lung Cancer
AstraZeneca 675
Testing effectiveness (Phase 2)Study completedNCT03228277
What this trial is testing

Olmutinib Trial in T790M (+) NSCLC Patients Detected by Liquid Biopsy Using BALF Extracellular Vesicular DNA

Who this might be right for
Non Small Cell Lung Cancer
Konkuk University Medical Center 25
Large-scale testing (Phase 3)Study completedNCT02027428
What this trial is testing

Safety and Efficacy Study of Abraxane as Maintenance Treatment After Abraxane Plus Carboplatin in 1st Line Stage IIIB / IV Squamous Cell Non-small Cell Lung Cancer

Who this might be right for
Squamous Cell Carcinoma, Non-Small-Cell Lung
Celgene 427
Testing effectiveness (Phase 2)Ended earlyNCT00776100
What this trial is testing

Radiation Therapy or Observation After Chemotherapy in Treating Patients With Stage IV Non-Small Cell Lung Cancer

Who this might be right for
Lung Cancer
Alliance for Clinical Trials in Oncology 3
Early research (Phase 1)Looking for participantsNCT06293898
What this trial is testing

Open Label Study to Evaluate BL-M07D1 in HER2 Expressing Malignant Solid Tumors

Who this might be right for
Endometrial CancerCervical CancerOvarian Cancer+7 more
SystImmune Inc. 280
Testing effectiveness (Phase 2)Active Not RecruitingNCT04791839
What this trial is testing

Safety and Efficacy of Zimberelimab (AB122) in Combination With Domvanalimab (AB154) and Etrumadenant (AB928) in Patients With Previously Treated Non-Small Cell Lung Cancer

Who this might be right for
Non Small Cell Lung CancerNon-small Cell CarcinomaNon-small Cell Lung Cancer
Washington University School of Medicine 30
Next Page